Health care stocks fell Wednesday afternoon, with the NYSE Health Care Index shedding 0.7% and the Health Care Select Sector SPDR Fund (XLV) down 0.8%.
The iShares Biotechnology ETF (IBB) declined 1.4%.
In corporate news, Lumos Pharma (LUMO) shares jumped 7.2% after the company agreed to be acquired by a unit of Double Point Ventures.
Fortrea (FTRE) shares popped 2.5% after media reports said that activist investor Corvex Management acquired a stake in the contract research firm.
Boston Scientific (BSX) raised its 2024 guidance on Wednesday after logging stronger-than-expected growth in Q3 results. Its shares were falling 1.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.